Reducing inflammation in COPD: the evidence builds
AUTOR(ES)
Barnes, Neil
FONTE
BMJ Group
RESUMO
Anti‐inflammatory activity of a combination of an inhaled steroid and a long‐acting β2 agonist in COPD
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2117134Documentos Relacionados
- Spirometric screening for COPD: wishful thinking, not evidence
- Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial
- Inhaled corticosteroids in COPD: awaiting controlled trials.
- Cognitive impairment in COPD: a systematic review
- Biomarkers in COPD: time for a deep breath
